Description
The global genome editing/genome engineering market was valued at USD 3.8 billion in 2020 and is projected to reach USD 9.93 billion with a CAGR of 14.7% during the forecast period, 2021-2027. The increasing use of genome editing/genome engineering, rising Clustered regularly interspaced short palindromic repeats (CRISPR) technology, and advancements in Genome Editing technology are the major factors restoring the growth of the Genome Editing/Genome Engineering Market. Furthermore, the increasing use of genetically altered crops and the technological advancements in the field. The willingness of the government to provide ample funding for further research and development in the area is among the key factors expected over the forecast period to drive the global market’s growth for genome editing/genome engineering.
